Literature DB >> 24899141

Differential clinicopathologic and genetic features of late-onset amnestic dementias.

Melissa E Murray1, Ashley Cannon, Neill R Graff-Radford, Amanda M Liesinger, Nicola J Rutherford, Owen A Ross, Ranjan Duara, Minerva M Carrasquillo, Rosa Rademakers, Dennis W Dickson.   

Abstract

Hippocampal sclerosis of the elderly (HpScl) and Alzheimer's disease (AD), especially the limbic-predominant subtype (LP-AD), are amnestic syndromes that can be difficult to distinguish. To complicate matters, a subset has concomitant HpScl and AD (HpScl-AD). We examined a large cohort of autopsy-confirmed cases of HpScl, HpScl-AD, LP-AD, and typical AD to identify distinct clinical, genetic, and pathologic characteristics. HpScl cases were significantly older at death and had a substantially slower rate of cognitive decline than the AD subtypes. Genetic analysis revealed that the AD groups (AD, LP-AD, and HpScl-AD) were more likely to be APOE ε4 carriers. In contrast, the HpScl groups (HpScl and HpScl-AD) were more likely to exhibit genetic variants in GRN and TMEM106B that are associated with frontotemporal lobar degeneration. The HpScl groups had a high frequency of TDP-43 pathology that was most often Type A morphology and distribution, while typical AD and LP-AD had a significantly lower frequency of TDP-43 pathology that was most often Type B. These results suggest that HpScl and AD are pathologically and genetically distinct and non-synergistic neurodegenerative processes that present with amnestic dementia. Pure HpScl and HpScl with concomitant AD occur most often in elderly individuals.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24899141      PMCID: PMC4412022          DOI: 10.1007/s00401-014-1302-2

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  35 in total

1.  TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia.

Authors:  Marka van Blitterswijk; Bianca Mullen; Alexandra M Nicholson; Kevin F Bieniek; Michael G Heckman; Matthew C Baker; Mariely DeJesus-Hernandez; Nicole A Finch; Patricia H Brown; Melissa E Murray; Ging-Yuek R Hsiung; Heather Stewart; Anna M Karydas; Elizabeth Finger; Andrew Kertesz; Eileen H Bigio; Sandra Weintraub; Marsel Mesulam; Kimmo J Hatanpaa; Charles L White; Michael J Strong; Thomas G Beach; Zbigniew K Wszolek; Carol Lippa; Richard Caselli; Leonard Petrucelli; Keith A Josephs; Joseph E Parisi; David S Knopman; Ronald C Petersen; Ian R Mackenzie; William W Seeley; Lea T Grinberg; Bruce L Miller; Kevin B Boylan; Neill R Graff-Radford; Bradley F Boeve; Dennis W Dickson; Rosa Rademakers
Journal:  Acta Neuropathol       Date:  2014-01-03       Impact factor: 17.088

2.  TMEM106B: a strong FTLD disease modifier.

Authors:  Yuetiva Deming; Carlos Cruchaga
Journal:  Acta Neuropathol       Date:  2014-02-01       Impact factor: 17.088

3.  Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly.

Authors:  Dennis W Dickson; Matthew Baker; Rosa Rademakers
Journal:  Neurodegener Dis       Date:  2010-03-03       Impact factor: 2.977

4.  Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.

Authors:  Tetsuaki Arai; Ian R A Mackenzie; Masato Hasegawa; Takashi Nonoka; Kazhuhiro Niizato; Kuniaki Tsuchiya; Shuji Iritani; Mitsumoto Onaya; Haruhiko Akiyama
Journal:  Acta Neuropathol       Date:  2009-01-13       Impact factor: 17.088

5.  An association study between granulin gene polymorphisms and Alzheimer's disease in Finnish population.

Authors:  Jayashree Viswanathan; Petra Mäkinen; Seppo Helisalmi; Annakaisa Haapasalo; Hilkka Soininen; Mikko Hiltunen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-07-05       Impact factor: 3.568

6.  Hippocampal sclerosis of aging is a key Alzheimer's disease mimic: clinical-pathologic correlations and comparisons with both alzheimer's disease and non-tauopathic frontotemporal lobar degeneration.

Authors:  Willa D Brenowitz; Sarah E Monsell; Frederick A Schmitt; Walter A Kukull; Peter T Nelson
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

7.  Focal cortical presentations of Alzheimer's disease.

Authors:  S Alladi; J Xuereb; T Bak; P Nestor; J Knibb; K Patterson; J R Hodges
Journal:  Brain       Date:  2007-10       Impact factor: 13.501

8.  TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions.

Authors:  Michael D Gallagher; Eunran Suh; Murray Grossman; Lauren Elman; Leo McCluskey; John C Van Swieten; Safa Al-Sarraj; Manuela Neumann; Ellen Gelpi; Bernardino Ghetti; Jonathan D Rohrer; Glenda Halliday; Christine Van Broeckhoven; Danielle Seilhean; Pamela J Shaw; Matthew P Frosch; Irina Alafuzoff; Anna Antonell; Nenad Bogdanovic; William Brooks; Nigel J Cairns; Johnathan Cooper-Knock; Carl Cotman; Patrick Cras; Marc Cruts; Peter P De Deyn; Charles DeCarli; Carol Dobson-Stone; Sebastiaan Engelborghs; Nick Fox; Douglas Galasko; Marla Gearing; Ilse Gijselinck; Jordan Grafman; Päivi Hartikainen; Kimmo J Hatanpaa; J Robin Highley; John Hodges; Christine Hulette; Paul G Ince; Lee-Way Jin; Janine Kirby; Julia Kofler; Jillian Kril; John B J Kwok; Allan Levey; Andrew Lieberman; Albert Llado; Jean-Jacques Martin; Eliezer Masliah; Christopher J McDermott; Ann McKee; Catriona McLean; Simon Mead; Carol A Miller; Josh Miller; David G Munoz; Jill Murrell; Henry Paulson; Olivier Piguet; Martin Rossor; Raquel Sanchez-Valle; Mary Sano; Julie Schneider; Lisa C Silbert; Salvatore Spina; Julie van der Zee; Tim Van Langenhove; Jason Warren; Stephen B Wharton; Charles L White; Randall L Woltjer; John Q Trojanowski; Virginia M Y Lee; Vivianna Van Deerlin; Alice S Chen-Plotkin
Journal:  Acta Neuropathol       Date:  2014-01-19       Impact factor: 17.088

9.  ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology.

Authors:  Peter T Nelson; Steven Estus; Erin L Abner; Ishita Parikh; Manasi Malik; Janna H Neltner; Eseosa Ighodaro; Wang-Xia Wang; Bernard R Wilfred; Li-San Wang; Walter A Kukull; Kannabiran Nandakumar; Mark L Farman; Wayne W Poon; Maria M Corrada; Claudia H Kawas; David H Cribbs; David A Bennett; Julie A Schneider; Eric B Larson; Paul K Crane; Otto Valladares; Frederick A Schmitt; Richard J Kryscio; Gregory A Jicha; Charles D Smith; Stephen W Scheff; Joshua A Sonnen; Jonathan L Haines; Margaret A Pericak-Vance; Richard Mayeux; Lindsay A Farrer; Linda J Van Eldik; Craig Horbinski; Robert C Green; Marla Gearing; Leonard W Poon; Patricia L Kramer; Randall L Woltjer; Thomas J Montine; Amanda B Partch; Alexander J Rajic; KatieRose Richmire; Sarah E Monsell; Gerard D Schellenberg; David W Fardo
Journal:  Acta Neuropathol       Date:  2014-04-27       Impact factor: 15.887

10.  Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia.

Authors:  Rosa Rademakers; Jason L Eriksen; Matt Baker; Todd Robinson; Zeshan Ahmed; Sarah J Lincoln; Nicole Finch; Nicola J Rutherford; Richard J Crook; Keith A Josephs; Bradley F Boeve; David S Knopman; Ronald C Petersen; Joseph E Parisi; Richard J Caselli; Zbigniew K Wszolek; Ryan J Uitti; Howard Feldman; Michael L Hutton; Ian R Mackenzie; Neill R Graff-Radford; Dennis W Dickson
Journal:  Hum Mol Genet       Date:  2008-08-21       Impact factor: 6.150

View more
  83 in total

1.  Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A.

Authors:  Naoya Aoki; Melissa E Murray; Kotaro Ogaki; Shinsuke Fujioka; Nicola J Rutherford; Rosa Rademakers; Owen A Ross; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2014-11-04       Impact factor: 17.088

Review 2.  ABCC9/SUR2 in the brain: Implications for hippocampal sclerosis of aging and a potential therapeutic target.

Authors:  Peter T Nelson; Gregory A Jicha; Wang-Xia Wang; Eseosa Ighodaro; Sergey Artiushin; Colin G Nichols; David W Fardo
Journal:  Ageing Res Rev       Date:  2015-07-28       Impact factor: 10.895

3.  Association of MAPT H1 subhaplotypes with neuropathology of lewy body disease.

Authors:  Michael G Heckman; Koji Kasanuki; Rebecca R Brennan; Catherine Labbé; Emily R Vargas; Alexandra I Soto; Melissa E Murray; Shunsuke Koga; Dennis W Dickson; Owen A Ross
Journal:  Mov Disord       Date:  2019-06-24       Impact factor: 10.338

4.  Detergent Insoluble Proteins and Inclusion Body-Like Structures Immunoreactive for PRKDC/DNA-PK/DNA-PKcs, FTL, NNT, and AIFM1 in the Amygdala of Cognitively Impaired Elderly Persons.

Authors:  Jozsef Gal; Jing Chen; Yuriko Katsumata; David W Fardo; Wang-Xia Wang; Sergey Artiushin; Douglas Price; Sonya Anderson; Ela Patel; Haining Zhu; Peter T Nelson
Journal:  J Neuropathol Exp Neurol       Date:  2018-01-01       Impact factor: 3.685

5.  Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease.

Authors:  Val J Lowe; Emily S Lundt; Sabrina M Albertson; Scott A Przybelski; Matthew L Senjem; Joseph E Parisi; Kejal Kantarci; Bradley Boeve; David T Jones; David Knopman; Clifford R Jack; Dennis W Dickson; Ronald C Petersen; Melissa E Murray
Journal:  Alzheimers Dement       Date:  2019-06-04       Impact factor: 21.566

6.  Reply: LATE to the PART-y.

Authors:  Peter T Nelson; Dennis W Dickson; John Q Trojanowski; Clifford R Jack; Patricia A Boyle; Konstantinos Arfanakis; Rosa Rademakers; Irina Alafuzoff; Johannes Attems; Carol Brayne; Ian T S Coyle-Gilchrist; David W Fardo; Margaret E Flanagan; Glenda Halliday; Sally Hunter; Gregory A Jicha; Yuriko Katsumata; Claudia H Kawas; C Dirk Keene; Gabor G Kovacs; Walter A Kukull; Allan I Levey; Nazanin Makkinejad; Thomas J Montine; Melissa E Murray; Sukriti Nag; William W Seeley; Reisa A Sperling; Charles L White; Julie A Schneider
Journal:  Brain       Date:  2019-09-01       Impact factor: 13.501

7.  Loss of TMEM106B Ameliorates Lysosomal and Frontotemporal Dementia-Related Phenotypes in Progranulin-Deficient Mice.

Authors:  Zoe A Klein; Hideyuki Takahashi; Mengxiao Ma; Massimiliano Stagi; Melissa Zhou; TuKiet T Lam; Stephen M Strittmatter
Journal:  Neuron       Date:  2017-07-19       Impact factor: 17.173

Review 8.  Challenges of multimorbidity of the aging brain: a critical update.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2014-08-05       Impact factor: 3.575

9.  Brain atrophy in primary age-related tauopathy is linked to transactive response DNA-binding protein of 43 kDa.

Authors:  Keith A Josephs; Melissa E Murray; Nirubol Tosakulwong; Stephen D Weigand; David S Knopman; Ronald C Petersen; Clifford R Jack; Jennifer L Whitwell; Dennis W Dickson
Journal:  Alzheimers Dement       Date:  2019-05-02       Impact factor: 21.566

10.  LRRK2 variation and dementia with Lewy bodies.

Authors:  Michael G Heckman; Alexandra I Soto-Ortolaza; Monica Y Sanchez Contreras; Melissa E Murray; Otto Pedraza; Nancy N Diehl; Ronald Walton; Catherine Labbé; Oswaldo Lorenzo-Betancor; Ryan J Uitti; Jay van Gerpen; Nilüfer Ertekin-Taner; Glenn E Smith; Kejal Kantarci; Rodolfo Savica; David T Jones; Jonathan Graff-Radford; David S Knopman; Val J Lowe; Clifford R Jack; Ronald C Petersen; Joseph E Parisi; Rosa Rademakers; Zbigniew K Wszolek; Neill R Graff-Radford; Tanis J Ferman; Dennis W Dickson; Bradley F Boeve; Owen A Ross
Journal:  Parkinsonism Relat Disord       Date:  2016-07-29       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.